2009 Free to Breathe Young Investigator Research Grant
Sai Yendamuri, MD
Roswell Park Cancer Institute / State University of New York at Buffalo
Research Project:
Predicting Recurrence of Lung Cancer
Summary:
Although early stage lung cancer is often curable with surgery, up to 30% to 40% of these cancers will recur. Predicting which patients have a high risk of recurrence would allow more aggressive treatment in the beginning, potentially curing more people. Dr. Yendamuri’s research aims to understand whether looking at a set of genetic components, micro RNAs, can predict who will experience disease recurrence, and whether these micro RNAs can be used to detect recurrence earlier than is now possible.